The latest report by IMARC Group, titled, “India Pharmaceutical Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” offers a comprehensive analysis of the industry, which comprises insights on the market. The report also includes competitor and regional analysis, and contemporary advancements in the market.

The Indian pharmaceutical market size reached US$ 48.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 102.7 Billion by 2028, exhibiting a growth rate (CAGR) of 13.01% during 2023-2028.

Pharmaceuticals are substances or compounds formulated to diagnose, treat, prevent, or alleviate medical conditions and diseases in humans and animals. These products play a pivotal role in modern healthcare by providing therapeutic solutions that target specific health issues. The pharmaceutical industry encompasses an extensive range of activities, from the initial discovery and development of new drug compounds to their rigorous testing, regulatory approval, and eventual manufacturing and distribution.

Pharmaceutical products can include prescription medications, over-the-counter drugs, vaccines, biologics, and various types of therapies, such as gene therapies and monoclonal antibodies. The development of pharmaceuticals involves in-depth research involving pharmacology, chemistry, biology, and clinical trials, to ensure their safety, effectiveness, and appropriate dosing.

Get a Free Sample Copy of the Report at – https://www.imarcgroup.com/india-pharmaceutical-market/requestsample

Industry Growth:

The India market is majorly driven by the continuous stream of innovation in drug discovery and development. Breakthroughs in areas such as biotechnology, genomics, and personalized medicine are revolutionizing the way pharmaceuticals are researched and produced. This is leading to the development of targeted therapies, precision medicine, and novel treatment modalities that hold the promise of more effective and tailored healthcare solutions.

Additionally, the aging global population and the prevalence of chronic diseases are fueling the demand for pharmaceutical products. As healthcare awareness increases and access to medical services expands, there is a growing need for medications that address a wide spectrum of health conditions, ranging from cardiovascular diseases to rare genetic disorders. The regulatory landscape also plays a significant role in shaping the pharmaceutical market.

Explore the Full Report with Charts, Table of Contents, and List of Figures: https://www.imarcgroup.com/india-pharmaceutical-market

India Pharmaceutical Market 2023-2028 Analysis and Segmentation:

Competitive Landscape with Key Players:

  • Abbott India Limited (Abbott Laboratories)
  • Aurobindo Pharma Limited
  • Biocon Limited
  • Cadila Pharmaceuticals Limited (CPL)
  • Cipla Limited
  • Divi’s Laboratories Limited
  • Reddy’s Laboratories Ltd.
  • GlaxoSmithKline Pharmaceuticals Limited (GSK plc)
  • Lupin Limited
  • Mankind Pharma Ltd.
  • Merck India Private Limited
  • Novartis India Limited (Novartis AG)
  • Pfizer Healthcare India Pvt. Ltd. (Pfizer Inc.)
  • Sun Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd. (Torrent Group)

Breakup by Type:

  • Pharmaceutical Drugs
    • Cardiovascular Drugs
    • Dermatology Drugs
    • Gastrointestinal Drugs
    • Genito-Urinary Drugs
    • Hematology Drugs
    • Anti-Infective Drugs
    • Metabolic Disorder Drugs
    • Musculoskeletal Disorder Drugs
    • Central Nervous System Drugs
    • Oncology Drugs
    • Ophthalmology Drugs
    • Respiratory Diseases Drugs
  • Biologics
    • Monoclonal Antibodies (MAbS)
    • Therapeutic Proteins
    • Vaccines

Breakup by Nature:

  • Organic
  • Conventional

Breakup by Region:

  • North India
  • West and Central India
  • South India
  • East India

Key Highlights of the Report:

  • Market Performance
  • Market Outlook 
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology, and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800